AAAAAA

   
Results: 1-9 |
Results: 9
Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy
Authors: Wikell, C Kugelberg, FC Hjorth, S Apelqvist, G Bengtsson, F
Citation: C. Wikell et al., Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy, CLIN NEUROP, 24(6), 2001, pp. 324-333
Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings
Authors: Wikell, C Hjorth, S Apelqvist, G Kullingsjo, J Lundmark, J Bergqvist, PBF Bengtsson, F
Citation: C. Wikell et al., Sustained administration of the antidepressant venlafaxine in rats: pharmacokinetic and pharmacodynamic findings, N-S ARCH PH, 363(4), 2001, pp. 448-455
In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats
Authors: Kugelberg, FC Apelqvist, G Carlsson, B Ahlner, J Bengtsson, F
Citation: Fc. Kugelberg et al., In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats, BR J PHARM, 132(8), 2001, pp. 1683-1690
Psychopharmacological aspects on monoaminergic and behavioral perturbations in experimental chronic hepatic encephalopathy
Authors: Apelqvist, G
Citation: G. Apelqvist, Psychopharmacological aspects on monoaminergic and behavioral perturbations in experimental chronic hepatic encephalopathy, NORD J PSY, 54(2), 2000, pp. 150-151
Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy
Authors: Apelqvist, G Wikell, C Carlsson, B Hjorth, S Bergqvist, PBF Ahlner, J Bengtsson, F
Citation: G. Apelqvist et al., Dynamic and kinetic effects of chronic citalopram treatment in experimental hepatic encephalopathy, CLIN NEUROP, 23(6), 2000, pp. 304-317
Altered open-field behavior in experimental chronic hepatic encephalopathyafter single venlafaxine and citalopram challenges
Authors: Apelqvist, G Wikell, C Hindfelt, B Bergqvist, PBF Andersson, G Bengtsson, F
Citation: G. Apelqvist et al., Altered open-field behavior in experimental chronic hepatic encephalopathyafter single venlafaxine and citalopram challenges, PSYCHOPHAR, 143(4), 1999, pp. 408-416
Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: Effects of systemic ammonium acetate and L-tryptophan
Authors: Bergqvist, PBF Carpenedo, R Apelqvist, G Moroni, F Bengtsson, F
Citation: Pbf. Bergqvist et al., Plasma and brain levels of oxindole in experimental chronic hepatic encephalopathy: Effects of systemic ammonium acetate and L-tryptophan, PHARM TOX, 85(3), 1999, pp. 138-143
Pharmacokinetic and pharmacodynamic responses to chronic administration ofthe selective serotonin reuptake inhibitor citalopram in rats
Authors: Wikell, C Apelqvist, G Carlsson, B Hjorth, S Bergqvist, PBF Kugelberg, FC Ahlner, J Bengtsson, F
Citation: C. Wikell et al., Pharmacokinetic and pharmacodynamic responses to chronic administration ofthe selective serotonin reuptake inhibitor citalopram in rats, CLIN NEUROP, 22(6), 1999, pp. 327-336
Quantitative studies of testicular atrophy following portacaval shunt in rats
Authors: Zaitoun, AM Apelqvist, G Wikell, C Al-Mardini, H Bengtsson, F Record, CO
Citation: Am. Zaitoun et al., Quantitative studies of testicular atrophy following portacaval shunt in rats, HEPATOLOGY, 28(6), 1998, pp. 1461-1466
Risultati: 1-9 |